US › Healthcare

Quantum Cyber N.V. (QUCY)

US · Healthcare · Diagnostics & Research

$1.36+3.82%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Revenue YoY

-100.0%

Net profit

$-11.0M

EPS

$-0.56

EPS estimate

$-0.63

EPS came in at -0.56 against a street estimate of -0.63 — a beat of 11.1%.

Key statistics

Market cap

$112.7M

Forward P/E

0.0

P/B

5.59

Book value

$0.81

EPS (TTM)

$-2.41

52-week high

$4.93

52-week low

$0.30

50-day MA

$1.34

200-day MA

$1.20

Beta

2.37

Analyst view

with an average price target of $9.00.

Shareholding

Insiders

70.73%

Institutions

0.29%

Largest institutional holders

Fund	Stake
UBS Group AG	0.10%
XTX Topco Ltd	0.08%
Steward Partners Investment Advisory, LLC	0.04%
Virtu Financial LLC	0.03%
Susquehanna International Group, LLP	0.02%
Jane Street Group LLC	0.02%
TWO SIGMA SECURITIES, LLC	0.02%
SBI Securities Co Ltd	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Quantum Cyber N.V. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.